Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Completed · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining lomustine, etoposide, cyclophosphamide, and procarbazine in treating patients who have AIDS-related non-Hodgkin's lymphoma.
Key facts
- Study ID
- NCT00049439
- Run by
- Case Comprehensive Cancer Center
- People needed
- 54
- Starts
- 1998-03-01
- Expected to finish
- 2008-02-01
- Last updated by the study team
- 2010-06-11
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Herbert Irving Comprehensive Cancer Center at Columbia University — New York, New York, United States
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
- University of Nairobi College of Health Sciences — Nairobi, Kenya
- Uganda Cancer Institute — Kampala, Uganda
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.